hs-cTnI Rapid Quantitative Test (Chemiluminescence Immunoassay)

Application

Cardiac troponin I (cTnI) is a protein with a molecular weight of 37 kDa and is a subunit of the troponin complex involved in theregulating muscle contraction.

Under normal conditions, the level of peripheral blood cTnI is low. However, when acute myocardial infarction (AMI) or local ischemic injury occurs, its concentration rises rapidly due to its small molecular weight, allowing for its quick release into the human bloodstream.

The high specificity of cTnI assays makes them very effective in identifying myocardial injury, allowing them to be clinically distinguished from skeletal muscle damage caused by surgery, trauma, overexertion, or muscle disease.

The quantification of cTnI concentrations in human serum, plasma, and venous whole blood samples is primarily used as an aid in the diagnosis of acute myocardial infarction (AMI). The measurement of cTnI is a sensitive and specific marker of myocardial cell injury, making it a valuable tool in the evaluation and management of patients with suspected or known acute coronary syndromes.

Product Specification

Features

Smart - Photosensitive and Luminescent Microspheres

Rapid - Whole Blood Sample Type Supported & No Centrifuge Needed

Convenient - Room Temperature Storage & Minimal sample consumption

Clinical significance

1. Early Diagnosis of Acute Myocardial Infarction (AMI)

2. Rapid Rule-In and Rule-Out of Myocardial Infarction

3. Monitoring Subclinical Cardiac Injury

4. Risk Stratification in Chronic Coronary Syndromes

5. Prognostic Marker for Cardiovascular Events